Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
12/2008
12/17/2008EP2001890A2 Tetrahydropyridothienopyrimidine compounds and methods of use thereof
12/17/2008EP2001889A1 Method for preparing clopidogrel 1,5-naphthalenedisulfonate or hydrate thereof
12/17/2008CN100443487C N-sulfonylheterocyclopyrrolylalkylamine compounds as 5-hydroxytryptamine-6 ligands
12/17/2008CN100443483C Condensed ring unit terminated oligomerized thiophen analog high mobility organic semi-conducting material and its uses
12/16/2008US7465742 Heterocyclic compounds having anti-HBV activity
12/16/2008US7465739 Cyclohexylthiophenepyrimidinone, cyclohexylpyrrolylpyrimidinone or cyclohexylfuranylpyrimidinone compounds for use in the treatment of a steroid hormone dependent diseases; inhibitor of 17 beta -hydroxysteroid dehydrogenase enzymes
12/16/2008US7465736 e.g. (2-chloropyrimidin-4-yl)-(4-ethyl-3H-thiazol-2ylidene)-acetonitrile,[4-(4-chlorophenyl)-1,3-thiazol-2(3H)-ylidene](2-chloropyrimidin-4-yl)acetonitrile; Jun N-terminal kinase and Glycogen Synthase Kinase 3 inhibitor; antidiabetic, antiinflammatory, anticarcinogenic agent; neurodegenerative diseases
12/16/2008US7465722 Biphenyl vasopressin agonists
12/14/2008CA2591644A1 Novel processes to form-i of olanzapine
12/11/2008WO2008149191A1 Hetero bicyclic carboxamide derivatives and their pharmaceutical use and compositions
12/11/2008WO2008109181A3 Metalloprotease inhibitors containing a heterocyclic moiety
12/11/2008US20080306107 Compounds
12/11/2008US20080306103 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor
12/11/2008US20080306101 Insecticidal Spironindane Derivatives
12/11/2008CA2690101A1 Hetero bicyclic carboxamide derivatives and their pharmaceutical use and compositions
12/10/2008EP1999135A2 Kinase inhibitors
12/10/2008EP1863479B1 Tetrahydrothiopyrano pyrazole cannabinoid modulators cross reference to related applications
12/10/2008EP1467735B1 Polymorphs of clopidogrel hydrogensulfate
12/10/2008CN101321766A Substituted benzofused derivatives and their use as vanilloid receptor ligands
12/09/2008US7462620 Pyrimidinone derivatives and their use in the treatment of atherosclerosis
12/04/2008WO2008147952A1 Modulators of cystic fibrosis transmembrane conductance regulator
12/04/2008WO2008147547A1 Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use
12/04/2008WO2008147544A1 Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use
12/04/2008WO2008146597A1 Method for producing aromatic compound
12/04/2008WO2008146249A1 Processes for the preparation of clopidogrel
12/04/2008WO2008146172A2 Compounds with antiparasitic activity, applications thereof to the treatment of infectious diseases caused by apicomplexans
12/04/2008WO2008144982A1 Compounds with 7-member cycle and the pharmaceutical use thereof for preventing and treating diabetes and metabolism syndrome
12/04/2008WO2008093357A3 Process for preparation of crystalline clopidogrel hydrogen sulphate form i
12/04/2008US20080300264 Substituted thiatriazaacenaphthylene-6-carbonitrile kinase inhibitors
12/04/2008US20080300200 Therapeutic Furopyrimidines and Thienopyrimidines
12/04/2008CA2688599A1 Compounds with antiparasitic activity, applications thereof to the treatment of infectious diseases caused by apicomplexans
12/04/2008CA2688495A1 Heptacyclic compounds and the pharmaceutical uses thereof for preventing and treating diabetes and metabolic syndrome
12/04/2008CA2688004A1 Modulators of cystic fibrosis transmembrane conductance regulator
12/04/2008CA2687608A1 Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use
12/03/2008EP1997822A1 Process for the preparation of 2-methyl-4-(4-methylpiperazin-1-yl)-10h-thieno-[2,3-b] [1,5] benzodiazepine dihydrochloride trihydrate, 2-methyl-4-(4-methyl-piperazin-1-yl) -10h-thieno[2,3-b] [1,5] benzodiazepine dihydrochloride trihydrate, pharmaceutical compositions comprising it and its use
12/03/2008EP1997821A1 Fluorine-containing compound and method for producing same, fluorine-containing polymer, organic thin film, and organic thin film device
12/03/2008EP1997805A1 Compounds with antiparasitic activity, applications thereof to the treatment of infectious diseases caused by apicomplexans
12/03/2008EP1996583A1 Thiazoles as nf-kb inhibitors (proteasome inhibitors)
12/03/2008EP1996579A2 Antibiotic compounds
12/03/2008EP1996553A2 Tumor necrosis factor alpha inhibitors and their use in the treatment of human diseases
12/03/2008EP1828198A4 Method for separating of optically pure thiophene compounds using simulated moving bed chromatography
12/03/2008EP1513516B1 SUBSTITUTED 3-AMINO-THIENO(2,3-b) PYRIDINE-2-CARBOXYLIC ACID AMIDE COMPOUNDS AND PROCESSES FOR PREPARING AND THEIR USES
12/03/2008CN101316851A Thienopyrimidinone derivatives as melanin concentrating hormone receptor-1 antagonists
12/02/2008US7459554 Anticancer agent; 1-(3-Benzyloxy-phenyl)-3-cyclobutyl-imidazo[1,5-a]pyrazin-8-ylamine
12/02/2008US7459459 8-(3-pentylamino)-2-methyl-3-(2-methyl-4-methoxyphenyl)-6,7-dihydro-5H-cyclopenta[d]pyrazolo[1,5-a]pyrimidine; corticotropin releasing factor receptor antagonist; antidepressant, anxiolytic agent; eating disorder, peptic ulcer, irritable bowl syndrome, Alzheimer's disease, drug addiction or alcoholism
12/02/2008US7459449 Olanzapine malonate, olanzapine glycolate, and olanzapine benzoate; antipsychotic agents; water soluble; can form tablets by direct compression; may be mixed with dibasic calcium phosphate and/or hydroxypropyl cellulose
11/2008
11/27/2008WO2008143262A1 Heterocyclic compound and use thereof
11/27/2008WO2008083367A3 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors
11/27/2008WO2008066664A3 Cis-cyclohexyl substituted pyrimidinone derivatives
11/27/2008WO2008024438A3 2-phenoxy pyrimidinone analogues
11/27/2008US20080293762 Preventive and Therapeutic medicament for gastroesophageal reflux disease
11/27/2008US20080293733 Axl kinase inhibitors
11/27/2008US20080293714 Tec Kinase Inhibitors
11/27/2008US20080293709 Novel 2-Amino-Heterocycles Useful in the Treatment of Abeta-Related Pathologies
11/27/2008US20080293678 Organic Nitric Oxide Donor Salts of Angiotensin Converting Enzyme Inhibitors, Compositions and Methods of Use
11/27/2008US20080293573 Use as pesticide, microbiocide, or herbicide
11/27/2008US20080293118 Magnetic fine particles having lower critical solution temperature
11/26/2008EP1994013A1 PROCESS FOR PRODUCING PURE AND STABLE FORM OF 2-METHYL-4-(4- METHYL- 1 -PIPERAZINYL)-10H-THIENO[2,3-b] [1,5]BENZODIAZEPINE
11/26/2008EP1337517B1 Pyrimidinone derivatives and their use in the treatment of atherosclerosis
11/26/2008EP1311487B1 Derivatives of 1,2-dihydro-7-hydroxyquinolines containing fused rings
11/26/2008CN101311179A Improved process for preparing thieno-benzodiazepine compounds
11/26/2008CN100436452C Pyrazole compounds useful as protein kinase inhibitors
11/26/2008CN100436425C Fused imidazolium derivatives
11/25/2008US7456192 3β-amino azabicyclooctane heteroaromatic amid derivatives preparation method and therapeutic uses thereof
11/25/2008US7455795 Polythiophenes; semiconductors
11/20/2008WO2008139228A2 Process for the purification of olanzapine
11/20/2008WO2008139009A1 Pyridothieneotriazines as antiangiogenic compounds
11/20/2008WO2008081473A3 Process for preparing clopidogrel
11/20/2008US20080287692 Synthesis of cyclopentadiene derivatives
11/20/2008US20080287679 Process for preparing clopidogrel
11/20/2008US20080287466 4-amino-2,3-disubstituted thieno [2,3,d]pyrimidines and pharmaceutical compositions thereof
11/20/2008US20080287465 Cyclic N-Hydroxy Imides as Inhibitors of Flap Endonuclease and Uses Thereof
11/20/2008US20080287449 Aza-tripeptide hepatitis c serine protease inhibitors
11/20/2008US20080287444 Pyrazole compounds useful as protein kinase inhibitors
11/20/2008US20080287432 6H-1-Thia-5,6-diaza-as-indacene-2-carboxylic acid [3-(3-trifluoromethyl-phenylcarbamoyl)-phenyl]-amide; treatment of kinase-associated diseases
11/20/2008US20080287430 Furan Compounds Useful As Ep1 Receptor Antagonists
11/20/2008CA2687143A1 Process for the purification of olanzapine
11/19/2008EP1991526A1 Tetracyclic indole derivatives as in vivo imaging agents and having peripheralbenzodiazepine receptor affinity (pbr)
11/19/2008CN101309925A Fused tetracyclic mglur1 antagonists as therapeutic agents
11/19/2008CN101309671A Stable composition for a pharmaceutical formulation containing olanzapine
11/19/2008CN100434420C Compound inhibiting dipeptidyl peptidase iv
11/18/2008US7452911 Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds
11/18/2008US7452905 Phenylalanine derivatives
11/18/2008CA2422379C Pyrazole compounds useful as protein kinase inhibitors
11/18/2008CA2248753C Use of olanzapine for treating excessive aggression
11/18/2008CA2124329C Compounds, compositions and methods for binding bio-affecting substances to surface membranes of bio-particles
11/13/2008WO2008137060A1 Thienopyridine and thiazolopyridine derivatives that inhibit prolyl hydroxylase activity
11/13/2008WO2008135770A2 Process for preparing dorzolam ide
11/13/2008WO2008135526A1 Carboxylic acid amides as factor xa inhibitors
11/13/2008WO2008135524A2 Substituted anthranilamides and analogues, manufacturing and use thereof as medicaments
11/13/2008WO2008135442A1 Heterocyclic compounds and their use as pesticides
11/13/2008WO2008118718A3 2-aminopyridine analogs as glucokinase activators
11/13/2008WO2008024433A3 Haloalkyl-substituted pyrimidinone derivatives
11/13/2008WO2007102037A3 A PROCESS FOR THE PREPARATION OF POLYMORPH FORM I OF (S)-(+)-METHYL-α-(2-CHLOROPHENYL)-6,7-DYHIDRO-THIENO-[3,2-c]PYRIDINE-5(4H)-ACETATE HYDROGEN SULFATE
11/13/2008US20080281074 Delivering nucleic acids to cells; complexing nucleic acid with polyampholte; contacting cell; biocompatible in vivo delivery; gene therapy
11/13/2008CA2685413A1 Process for preparing dorzolamide
11/13/2008CA2685216A1 Thienopyridine and thiazolopyridine derivatives that inhibit prolyl hydroxylase activity
11/13/2008CA2683821A1 Heterocyclic compounds and their use as pesticides
11/12/2008EP1989211A2 Heterobicyclic thiophene compounds for the treatment of cancer
11/12/2008EP1989210A2 A2a adenosine receptor antagonists
1 ... 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 ... 214